Device Trial Radar · NCT07221097
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
Last checked: Nov 20, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,091
Actual
Start
Sep 29, 2025
Primary completion
Mar 31, 2026
Study completion Apr 30, 2026
Sponsor
- Lead sponsor
- BioFire Defense LLCNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Children's Hospital Los Angeles; George Washington University; Wake Forest University Health Sciences; Tampa General Hospital; The University of Texas Medical Branch, Galveston; Emory University
- First posted
- Oct 27, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Biomedical Advanced Research and Development Authority (BARDA) has contracted BioFire Defense (BFDf) to develop the BioFire Emerging Coronavirus (ECoV) Panel, a nucleic acid test capable of detecting coronaviruses from nasopharyngeal swab (NPS) in transport medium. This study aims to evaluate the diagnostic accuracy of the assays comprising the BioFire ECoV Panel. It is hypothesized that the BioFire ECoV Panel assays will be highly sensitive and specific for the detection of the coronaviruses included on the panel.
Conditions
- Coronavirus
- Respiratory Infection
- COVID
Interventions
Investigational IVD for coronavirusesDevice
Device testing on prospectively collected specimens leftover from standard of care for IVD validation only; results will not influence patient care/management.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device PerformanceTime frame: Through study completion; September 2025-August 2026
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Children's Hospital Los Angeles
Los Angeles, California
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.